X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ABBOTT INDIA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ABBOTT INDIA STERLING BIOTECH/
ABBOTT INDIA
 
P/E (TTM) x -0.6 38.7 - View Chart
P/BV x 0.0 11.2 0.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 STERLING BIOTECH   ABBOTT INDIA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ABBOTT INDIA
Mar-17
STERLING BIOTECH/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs115,190 0.2%   
Low Rs34,351 0.1%   
Sales per share (Unadj.) Rs26.81,382.9 1.9%  
Earnings per share (Unadj.) Rs-15.0130.2 -11.5%  
Cash flow per share (Unadj.) Rs-5.5137.9 -4.0%  
Dividends per share (Unadj.) Rs040.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs54.9652.7 8.4%  
Shares outstanding (eoy) m267.8721.25 1,260.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 7.5%   
Avg P/E ratio x-0.536.6 -1.3%  
P/CF ratio (eoy) x-1.334.6 -3.7%  
Price / Book Value ratio x0.17.3 1.7%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m1,862101,373 1.8%   
No. of employees `0001.43.1 43.9%   
Total wages/salary Rs m5473,453 15.8%   
Avg. sales/employee Rs Th5,303.39,531.9 55.6%   
Avg. wages/employee Rs Th403.81,119.9 36.1%   
Avg. net profit/employee Rs Th-2,959.0897.3 -329.8%   
INCOME DATA
Net Sales Rs m7,18129,387 24.4%  
Other income Rs m43576 7.4%   
Total revenues Rs m7,22329,963 24.1%   
Gross profit Rs m9473,973 23.8%  
Depreciation Rs m2,543164 1,547.9%   
Interest Rs m4,37720 21,456.4%   
Profit before tax Rs m-5,9314,365 -135.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9241,598 -120.4%   
Profit after tax Rs m-4,0072,767 -144.8%  
Gross profit margin %13.213.5 97.5%  
Effective tax rate %32.436.6 88.6%   
Net profit margin %-55.89.4 -592.7%  
BALANCE SHEET DATA
Current assets Rs m14,33518,906 75.8%   
Current liabilities Rs m49,8096,297 791.1%   
Net working cap to sales %-494.042.9 -1,151.4%  
Current ratio x0.33.0 9.6%  
Inventory Days Days40362 648.7%  
Debtors Days Days17122 788.6%  
Net fixed assets Rs m55,4321,159 4,783.7%   
Share capital Rs m268213 126.1%   
"Free" reserves Rs m13,93513,657 102.0%   
Net worth Rs m14,70113,869 106.0%   
Long term debt Rs m9,4780-   
Total assets Rs m73,98820,638 358.5%  
Interest coverage x-0.4215.0 -0.2%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.11.4 6.8%   
Return on assets %0.513.5 3.7%  
Return on equity %-27.319.9 -136.6%  
Return on capital %-6.431.6 -20.3%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8600-   
Fx outflow Rs m250-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,7193,072 55.9%  
From Investments Rs m-3,148-1,554 202.6%  
From Financial Activity Rs m1,426-898 -158.9%  
Net Cashflow Rs m-3621 -0.5%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 9.9 0.1 9,900.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 17.1 229.8%  
Shareholders   21,482 18,270 117.6%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  AJANTA PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare STERLING BIOTECH With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Jun 18, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS